Details of the Drug

General Information of Drug (ID: DMRX7UZ)

• Drug Name: KP415

Indication

Disease Entry	ICD 11	Status	REF
Attention deficit hyperactivity disorder	6A05.Z	Phase 3	[1]

• Cross-matching ID: TTD ID: D0O1EH

References

• [1] ClinicalTrials.gov (NCT03460652) KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD. U.S. National Institutes of Health.